Efficacy and safety of lornoxicam use for the rapid relief of pain syndromes in patients with oncological diseases in general somatic practice
Treatment of cancer patients in somatic hospitals, which includes the mandatory pain management, is a major medical problem. The results of non-steroidal anti-inflammatory drug Lornoxicam administration of this purpose in comparison with "traditional" analgesics are presented. In the study, including 130 patients with malignant tumors, it is shown that the severity and duration of analgesic action lornoxicam exceed action of such drugs as tramadol, baralgin and prosidol. In addition, the lornoxicam administration was significantly less frequently accompanied by the development of side effects.

Keywords: chronic pain, non-steroidal anti-inflammatory drugs, cancer